Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global IBS-C Drug market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global IBS-C Drug market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Linaclotide Lubiprostone Osmotic Laxatives Stimulant Laxatives Other Segmented by End User/Segment Hospital Pharmacies Retail Pharmacies Online Pharmacies Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Yuhan Corp The Menarini Group Teva Pharmaceutical Industries Synthetic Biologics Synergy Pharmaceuticals Sucampo Pharmaceuticals Salix Pharmaceuticals Prometheus Laboratories Ono Pharmaceutical Novartis Pharma Norgine Nestle Ironwood Pharmaceuticals Ferring BV Catalent Pharmaceuticals Solutions Bama-Geve Astrazeneca Astellas Pharmaceuticals Ardelyx Albireo Pharma Actavis Nordic Abbott Laboratories

List of Figures

Figure IBS-C Drug Picture
Figure Global IBS-C Drug Sales Volume and Growth Rate (2016-2027)
Figure Global IBS-C Drug Sales Value and Growth Rate (2016-2027)
Figure Global IBS-C Drug Sales Value CAGR (2020-2027) by Region
Figure Global IBS-C Drug Sales Volume Market Share by Company, 2020
Figure Global IBS-C Drug Sales Value Market Share by Company, 2020
Figure Global IBS-C Drug Sales Value and Growth Rate (2016-2027)
Figure Product Picture of Linaclotide
Figure Product Picture of Lubiprostone
Figure Product Picture of Osmotic Laxatives
Figure Product Picture of Stimulant Laxatives
Figure Product Picture of Other
Figure Global IBS-C Drug Sales Volume Market Share by Category, 2020
Figure Global IBS-C Drug Sales Value Market Share by Category, 2020
Figure North America IBS-C Drug Sales Volume Market Share by Category, 2020
Figure Europe IBS-C Drug Sales Volume Market Share by Category, 2020
Figure Asia Pacific IBS-C Drug Sales Volume Market Share by Category, 2020
Figure Central & South America IBS-C Drug Sales Volume Market Share by Category, 2020
Figure Middle East & Africa IBS-C Drug Sales Volume Market Share by Category, 2020
Figure IBS-C Drug in Hospital Pharmacies
Figure Global IBS-C Drug Market: Hospital Pharmacies (2016-2021)
Figure IBS-C Drug in Retail Pharmacies
Figure Global IBS-C Drug Market: Retail Pharmacies (2016-2021)
Figure IBS-C Drug in Online Pharmacies
Figure Global IBS-C Drug Market: Online Pharmacies (2016-2021)
Figure Global IBS-C Drug Sales Volume Market Share by End User/Segment, 2020
Figure Global IBS-C Drug Sales Value Market Share by End User/Segment, 2020
Figure North America IBS-C Drug Sales Volume Market Share by End User/Segment, 2020
Figure Europe IBS-C Drug Sales Volume Market Share by End User/Segment, 2020
Figure Asia Pacific IBS-C Drug Sales Volume Market Share by End User/Segment, 2020
Figure Central & South America IBS-C Drug Sales Volume Market Share by End User/Segment, 2020
Figure Middle East & Africa IBS-C Drug Sales Volume Market Share by End User/Segment, 2020
Figure Global IBS-C Drug Sales Volume Market Share by Region (2016-2021)
Figure Global IBS-C Drug Sales Value Market Share by Region (2016-2021)
Figure North America IBS-C Drug Sales Volume Status (2016-2021)
Figure North America IBS-C Drug Sales Value Status (2016-2021)
Figure Europe IBS-C Drug Sales Volume Status (2016-2021)
Figure Europe IBS-C Drug Sales Value Status (2016-2021)
Figure Asia Pacific IBS-C Drug Sales Volume Status (2016-2021)
Figure North America IBS-C Drug Sales Value Status (2016-2021)
Figure Central & South America IBS-C Drug Sales Volume Status (2016-2021)
Figure Europe IBS-C Drug Sales Value Status (2016-2021)
Figure Middle East & Africa IBS-C Drug Sales Volume Status (2016-2021)
Figure China IBS-C Drug Sales Value Status (2016-2021)
Figure North America IBS-C Drug Sales Volume Market Share by Country, 2020
Figure Japan IBS-C Drug Sales Value Status (2016-2021)
Figure United States IBS-C Drug Sales Volume Status (2016-2021)
Figure Asia Other IBS-C Drug Sales Value Status (2016-2021)
Figure Canada IBS-C Drug Sales Volume Status (2016-2021)
Figure Canada IBS-C Drug Sales Value Status (2016-2021)
Figure Mexico IBS-C Drug Sales Volume Status (2016-2021)
Figure Mexico IBS-C Drug Sales Value Status (2016-2021)
Figure Europe IBS-C Drug Sales Volume Market Share by Country, 2020
Figure Europe IBS-C Drug Value Market Share by Country, 2020
Figure Germany IBS-C Drug Sales Volume Status (2016-2021)
Figure Germany IBS-C Drug Sales Value Status (2016-2021)
Figure France IBS-C Drug Sales Volume Status (2016-2021)
Figure France IBS-C Drug Sales Value Status (2016-2021)
Figure UK IBS-C Drug Sales Volume Status (2016-2021)
Figure UK IBS-C Drug Sales Value Status (2016-2021)
Figure Italy IBS-C Drug Sales Volume Status (2016-2021)
Figure Italy IBS-C Drug Sales Value Status (2016-2021)
Figure Russia IBS-C Drug Sales Volume Status (2016-2021)
Figure Russia IBS-C Drug Sales Value Status (2016-2021)
Figure Spain IBS-C Drug Sales Volume Status (2016-2021)
Figure Spain IBS-C Drug Sales Value Status (2016-2021)
Figure Asia Pacific IBS-C Drug Sales Volume Market Share by Country, 2020
Figure Asia Pacific IBS-C Drug Value Market Share by Country, 2020
Figure China IBS-C Drug Sales Volume Status (2016-2021)
Figure China IBS-C Drug Sales Value Status (2016-2021)
Figure Japan IBS-C Drug Sales Volume Status (2016-2021)
Figure Japan IBS-C Drug Sales Value Status (2016-2021)
Figure Korea IBS-C Drug Sales Volume Status (2016-2021)
Figure Korea IBS-C Drug Sales Value Status (2016-2021)
Figure Southeast Asia IBS-C Drug Sales Volume Status (2016-2021)
Figure Southeast Asia IBS-C Drug Sales Value Status (2016-2021)
Figure India IBS-C Drug Sales Volume Status (2016-2021)
Figure India IBS-C Drug Sales Value Status (2016-2021)
Figure Australasia IBS-C Drug Sales Volume Status (2016-2021)
Figure Australasia IBS-C Drug Sales Value Status (2016-2021)
Figure Central & South America IBS-C Drug Sales Volume Market Share by Country, 2020
Figure Central & South America IBS-C Drug Sales Value Market Share by Country, 2020
Figure Brazil IBS-C Drug Sales Volume Status (2016-2021)
Figure Brazil IBS-C Drug Sales Value Status (2016-2021)
Figure Argentina IBS-C Drug Sales Volume Status (2016-2021)
Figure Argentina IBS-C Drug Sales Value Status (2016-2021)
Figure Colombia IBS-C Drug Sales Volume Status (2016-2021)
Figure Colombia IBS-C Drug Sales Value Status (2016-2021)
Figure Middle East & Africa IBS-C Drug Sales Volume Market Share by Country, 2020
Figure Middle East & Africa IBS-C Drug Value Market Share by Country, 2020
Figure Iran IBS-C Drug Sales Volume Status (2016-2021)
Figure Iran IBS-C Drug Sales Value Status (2016-2021)
Figure South Africa IBS-C Drug Sales Volume Status (2016-2021)
Figure South Africa IBS-C Drug Sales Value Status (2016-2021)
Figure Israel IBS-C Drug Sales Volume Status (2016-2021)
Figure Israel IBS-C Drug Sales Value Status (2016-2021)
Figure Turkey IBS-C Drug Sales Volume Status (2016-2021)
Figure Turkey IBS-C Drug Sales Value Status (2016-2021)
Figure Saudi Arabia IBS-C Drug Sales Volume Status (2016-2021)
Figure Saudi Arabia IBS-C Drug Sales Value Status (2016-2021)
Figure IBS-C Drug Supply Chain Analysis
Figure IBS-C Drug Production Process Chart Analysis
Figure IBS-C Drug Manufacturing Cost Analysis
Figure Global IBS-C Drug Sales Volume Forecast (2022-2027)
Figure Global IBS-C Drug Sales Value Forecast (2022-2027)
Figure North America IBS-C Drug Sales Volume Forecast (2022-2027)
Figure North America IBS-C Drug Sales Value Forecast (2022-2027)
Figure Global IBS-C Drug Sales Value Growth Rate Forecast (2022-2027)
Figure Europe IBS-C Drug Sales Value Forecast (2022-2027)
Figure Asia Pacific IBS-C Drug Sales Volume Forecast (2022-2027)
Figure North America IBS-C Drug Sales Value Forecast (2022-2027)
Figure Central & South America IBS-C Drug Sales Volume Forecast (2022-2027)
Figure Europe IBS-C Drug Sales Value Forecast (2022-2027)
Figure Middle East & Africa IBS-C Drug Sales Volume Forecast (2022-2027)
Figure China IBS-C Drug Sales Value Forecast (2022-2027)
Figure Japan IBS-C Drug Sales Value Forecast (2022-2027)
Figure Asia Other IBS-C Drug Sales Value Forecast (2022-2027)
Figure Yuhan Corp IBS-C Drug Sales Volume Market Share Globally (2019-2021)
Figure Yuhan Corp IBS-C Drug Sales Value Market Share Globally (2019-2021)
Figure The Menarini Group IBS-C Drug Sales Volume Market Share Globally (2019-2021)
Figure The Menarini Group IBS-C Drug Sales Value Market Share Globally (2019-2021)
Figure Teva Pharmaceutical Industries IBS-C Drug Sales Volume Market Share Globally (2019-2021)
Figure Teva Pharmaceutical Industries IBS-C Drug Sales Value Market Share Globally (2019-2021)
Figure Synthetic Biologics IBS-C Drug Sales Volume Market Share Globally (2019-2021)
Figure Synthetic Biologics IBS-C Drug Sales Value Market Share Globally (2019-2021)
Figure Synergy Pharmaceuticals IBS-C Drug Sales Volume Market Share Globally (2019-2021)
Figure Synergy Pharmaceuticals IBS-C Drug Sales Value Market Share Globally (2019-2021)
Figure Sucampo Pharmaceuticals IBS-C Drug Sales Volume Market Share Globally (2019-2021)
Figure Sucampo Pharmaceuticals IBS-C Drug Sales Value Market Share Globally (2019-2021)
Figure Salix Pharmaceuticals IBS-C Drug Sales Volume Market Share Globally (2019-2021)
Figure Salix Pharmaceuticals IBS-C Drug Sales Value Market Share Globally (2019-2021)
Figure Prometheus Laboratories IBS-C Drug Sales Volume Market Share Globally (2019-2021)
Figure Prometheus Laboratories IBS-C Drug Sales Value Market Share Globally (2019-2021)
Figure Ono Pharmaceutical IBS-C Drug Sales Volume Market Share Globally (2019-2021)
Figure Ono Pharmaceutical IBS-C Drug Sales Value Market Share Globally (2019-2021)
Figure Novartis Pharma IBS-C Drug Sales Volume Market Share Globally (2019-2021)
Figure Novartis Pharma IBS-C Drug Sales Value Market Share Globally (2019-2021)

Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global IBS-C Drug Market Status and Forecast (2016-2027) 1.3.2 Global IBS-C Drug Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global IBS-C Drug Supply by Company 2.1 Global IBS-C Drug Sales Volume by Company 2.2 Global IBS-C Drug Sales Value by Company 2.3 Global IBS-C Drug Price by Company 2.4 IBS-C Drug Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate3 Global and Regional IBS-C Drug Market Status by Category 3.1 IBS-C Drug Category Introduction 3.1.1 Linaclotide 3.1.2 Lubiprostone 3.1.3 Osmotic Laxatives 3.1.4 Stimulant Laxatives 3.1.5 Other 3.2 Global IBS-C Drug Market by Category 3.2.1 Global IBS-C Drug Sales Volume by Category (2016-2021) 3.2.2 Global IBS-C Drug Sales Value by Category (2016-2021) 3.2.3 Global IBS-C Drug Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional IBS-C Drug Market Status by End User/Segment 4.1 IBS-C Drug Segment by End User/Segment 4.1.1 Hospital Pharmacies 4.1.2 Retail Pharmacies 4.1.3 Online Pharmacies 4.2 Global IBS-C Drug Market by End User/Segment 4.2.1 Global IBS-C Drug Sales Volume by End User/Segment (2016-2021) 4.2.2 Global IBS-C Drug Sales Value by End User/Segment (2016-2021) 4.2.3 Global IBS-C Drug Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global IBS-C Drug Market Status by Region 5.1 Global IBS-C Drug Market by Region 5.1.1 Global IBS-C Drug Sales Volume by Region 5.1.2 Global IBS-C Drug Sales Value by Region 5.2 North America IBS-C Drug Market Status 5.3 Europe IBS-C Drug Market Status 5.4 Asia Pacific IBS-C Drug Market Status 5.5 Central & South America IBS-C Drug Market Status 5.6 Middle East & Africa IBS-C Drug Market Status6 North America IBS-C Drug Market Status 6.1 North America IBS-C Drug Market by Country 6.1.1 North America IBS-C Drug Sales Volume by Country (2016-2021) 6.1.2 North America IBS-C Drug Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico7 Europe IBS-C Drug Market Status 7.1 Europe IBS-C Drug Market by Country 7.1.1 Europe IBS-C Drug Sales Volume by Country (2016-2021) 7.1.2 Europe IBS-C Drug Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific IBS-C Drug Market Status 8.1 Asia Pacific IBS-C Drug Market by Country 8.1.1 Asia Pacific IBS-C Drug Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific IBS-C Drug Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America IBS-C Drug Market Status 9.1 Central & South America IBS-C Drug Market by Country 9.1.1 Central & South America IBS-C Drug Sales Volume by Country (2016-2021) 9.1.2 Central & South America IBS-C Drug Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa IBS-C Drug Market Status 10.1 Middle East & Africa IBS-C Drug Market by Country 10.1.1 Middle East & Africa IBS-C Drug Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa IBS-C Drug Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 IBS-C Drug Manufacturing Cost Analysis 11.5 IBS-C Drug Sales Channel and Distributors Analysis 11.5.1 IBS-C Drug Sales Channel 11.5.2 IBS-C Drug Distributors 11.6 IBS-C Drug Downstream Major Buyers12 Global IBS-C Drug Market Forecast by Category and by End User/Segment 12.1 Global IBS-C Drug Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global IBS-C Drug Forecast by Category 12.2.1 Global IBS-C Drug Sales Volume Forecast by Category 12.2.2 Global IBS-C Drug Sales Value Forecast by Category 12.2.3 Global IBS-C Drug Price Forecast by Category 12.3 Global IBS-C Drug Forecast by End User/Segment 12.3.1 Global IBS-C Drug Sales Volume Forecast by End User/Segment 12.3.2 Global IBS-C Drug Sales Value Forecast by End User/Segment 12.3.3 Global IBS-C Drug Price Forecast by End User/Segment13 Global IBS-C Drug Market Forecast by Region/Country 13.1 Global IBS-C Drug Market Forecast by Region (2022-2027) 13.1.1 Global IBS-C Drug Sales Volume Forecast by Region (2022-2027) 13.1.2 Global IBS-C Drug Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Yuhan Corp 14.1.1 Company Information 14.1.2 IBS-C Drug Product Introduction 14.1.3 Yuhan Corp IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 The Menarini Group 14.2.1 Company Information 14.2.2 IBS-C Drug Product Introduction 14.2.3 The Menarini Group IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Teva Pharmaceutical Industries 14.3.1 Company Information 14.3.2 IBS-C Drug Product Introduction 14.3.3 Teva Pharmaceutical Industries IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Synthetic Biologics 14.4.1 Company Information 14.4.2 IBS-C Drug Product Introduction 14.4.3 Synthetic Biologics IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Synergy Pharmaceuticals 14.5.1 Company Information 14.5.2 IBS-C Drug Product Introduction 14.5.3 Synergy Pharmaceuticals IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 Sucampo Pharmaceuticals 14.6.1 Company Information 14.6.2 IBS-C Drug Product Introduction 14.6.3 Sucampo Pharmaceuticals IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 Salix Pharmaceuticals 14.7.1 Company Information 14.7.2 IBS-C Drug Product Introduction 14.7.3 Salix Pharmaceuticals IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 Prometheus Laboratories 14.8.1 Company Information 14.8.2 IBS-C Drug Product Introduction 14.8.3 Prometheus Laboratories IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 14.9 Ono Pharmaceutical 14.9.1 Company Information 14.9.2 IBS-C Drug Product Introduction 14.9.3 Ono Pharmaceutical IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.9.4 SWOT Analysis 14.10 Novartis Pharma 14.10.1 Company Information 14.10.2 IBS-C Drug Product Introduction 14.10.3 Novartis Pharma IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.10.4 SWOT Analysis 14.11 Norgine 14.12 Nestle 14.13 Ironwood Pharmaceuticals 14.14 Ferring BV 14.15 Catalent Pharmaceuticals Solutions 14.16 Bama-Geve 14.17 Astrazeneca 14.18 Astellas Pharmaceuticals 14.19 Ardelyx 14.20 Albireo Pharma 14.21 Actavis Nordic 14.22 Abbott Laboratories15 Conclusion16 Methodology